Jane Street’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.43M Sell
96,923
-179,935
-65% -$7.32M ﹤0.01% 4114
2025
Q4
$11.2M Buy
276,858
+231,069
+505% +$10.1M ﹤0.01% 2188
2025
Q3
$2.15M Sell
45,789
-75,676
-62% -$3.92M ﹤0.01% 4804
2025
Q2
$6.33M Buy
121,465
+60,151
+98% +$3.3M ﹤0.01% 2704
2025
Q1
$3.7M Buy
61,314
+51,962
+556% +$3.35M ﹤0.01% 3382
2024
Q4
$640K Sell
9,352
-30,240
-76% -$2.11M ﹤0.01% 6248
2024
Q3
$2.85M Sell
39,592
-19,749
-33% -$1.39M ﹤0.01% 3824
2024
Q2
$4.11M Buy
59,341
+25,768
+77% +$1.88M ﹤0.01% 3281
2024
Q1
$2.69M Sell
33,573
-12,363
-27% -$1.1M ﹤0.01% 3591
2023
Q4
$5.03M Buy
45,936
+29,566
+181% +$3.06M ﹤0.01% 2844
2023
Q3
$1.65M Sell
16,370
-25,177
-61% -$2.89M ﹤0.01% 4358
2023
Q2
$5.65M Sell
41,547
-18,748
-31% -$2.29M ﹤0.01% 2570
2023
Q1
$6.26M Buy
60,295
+39,413
+189% +$3.81M ﹤0.01% 2152
2022
Q4
$1.85M Buy
20,882
+3,501
+20% +$290K ﹤0.01% 3979
2022
Q3
$1.39M Sell
17,381
-2,256
-11% -$213K ﹤0.01% 4828
2022
Q2
$1.88M Buy
19,637
+7,403
+61% +$888K ﹤0.01% 4281
2022
Q1
$1.82M Buy
12,234
+10,068
+465% +$1.41M ﹤0.01% 4931
2021
Q4
$307K Sell
2,166
-7,308
-77% -$1.04M ﹤0.01% 8127
2021
Q3
$1.24M Buy
9,474
+1,636
+21% +$214K ﹤0.01% 5477
2021
Q2
$1.08M Buy
7,838
+5,537
+241% +$758K ﹤0.01% 5672
2021
Q1
$300K Sell
2,301
-578
-20% -$69.6K ﹤0.01% 7707
2020
Q4
$322K Sell
2,879
-2,316
-45% -$219K ﹤0.01% 6298
2020
Q3
$409K Buy
+5,195
New +$424K ﹤0.01% 5457
2020
Q2
Sell
-3,736
Closed -$214K 7095
2020
Q1
$214K Buy
+3,736
New +$345K ﹤0.01% 4576

Other funds holding CNMD

Jane Street's CNMD Position: Q1 2026 in Review

Jane Street reduced its CONMED (CNMD) stake by 65% in Q1 2026, selling an estimated $7.32M and leaving 96,923 shares worth $3.43M. The position accounts for ﹤0.01% of the portfolio, ranked #4114.

Jane Street first reported a position in CNMD in Q1 2020 and has held it in 24 quarters since. The position peaked at $11.2M in Q4 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Jane Street held 96,923 shares of CONMED worth $3.43M as of Q1 2026.
  • Jane Street sold 179,935 CONMED shares in Q1 2026, an estimated $7.32M.
  • CONMED made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4114 holding.
  • Jane Street first reported a position in CONMED in Q1 2020 and has held it in 24 quarters since.
  • Jane Street's CONMED position peaked at $11.2M in Q4 2025.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.